![Kwing-Ming Tsoi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kwing-Ming Tsoi
Direktor/Vorstandsmitglied bei Innoforce Pharmaceuticals Co. Ltd.
Aktive Positionen von Kwing-Ming Tsoi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Innoforce Pharmaceuticals Co. Ltd.
![]() Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Kwing-Ming Tsoi
Statistik
International
China | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Innoforce Pharmaceuticals Co. Ltd.
![]() Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Health Technology |
- Börse
- Insiders
- Kwing-Ming Tsoi
- Erfahrung